He also explained how since both MDMA and psilocybin help “reduce inhibitions,” they could allow people to process difficult memories and images.
Still, come July, the drugs will be limited for use only among patients with depression and PTSD. However, advocates of the drugs hope that MDMA and psilocybin will one day be legalized for treatment among various other patients– including those affected by alcohol dependence, eating disorders, and obsessive-compulsive disorder (OCD).
This push in Australia came after authorities in the United States and Canada legalized the medical use of psilocybin and MDMA.
In July 2022, a letter from the U.S. Health and Human Services Department also revealed that the Biden administration “anticipates” that the FDA will approve MDMA and psilocybin for designated breakthrough therapies for depression and PTSD within two years.
If true crime defines your free time, this is for you: join Chip Chick’s True Crime Tribe